High Functionality Polyesters And Coatings Comprising The Same
US-2017267802-A1 · Sep 21, 2017 · US
US9631042B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9631042-B2 |
| Application number | US-201414539449-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 12, 2014 |
| Priority date | Dec 31, 2008 |
| Publication date | Apr 25, 2017 |
| Grant date | Apr 25, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention pertains to copolymers having one or more polyisobutylene segments and one or more biodegradable polymer segments, to methods of making such copolymers, to medical articles that contain such copolymers, and to methods of making such medical articles. According to certain aspects of the invention, copolymers are provided, which comprise a plurality of polyisobutylene segments and a plurality of biodegradable polymer segments. According to certain aspects of the invention, copolymers are provided, which comprise urethane linkages, urea linkages, amide linkages, ester linkages, anhydride linkages, carbonate linkages, linkages commonly described as “click” chemistry linkages, and combinations of two or more types of such linkages.
Opening claim text (preview).
The invention claimed is: 1. A medical article, comprising: a tubular member including a polymeric region, the polymeric region including a copolymer comprising a plurality of polyisobutylene segments having a number average molecular weight of 20,000 or less and a plurality of hard biodegradable polymer segments; and wherein the copolymer includes one or more linkages comprising a 1,2,3-triazole moiety. 2. The medical article of claim 1 , wherein the hard segments comprise a plurality of diisocyanate residues, a plurality of urethane linkages, a plurality of urea linkages, or a combination thereof. 3. The medical article of claim 1 , wherein the hard segments comprise a plurality of diisocyanate residues and wherein the diisocyanate residues comprise non-aromatic diisocyanate residues. 4. The medical article of claim 1 , wherein the hard segments comprise a plurality of diisocyanate residues wherein the diisocyanate residues comprise aromatic diisocyanate residues. 5. The medical article of claim 1 , wherein the hard segments comprise a plurality of diisocyanate residues wherein the diisocyanate residues comprise residues of an aromatic diisocyanate selected from 4,4′-methylenediphenyl diisocyanate, toluene diisocyanate, 1,5-naphthalene diisocyanate, para-phenylene diisocyanate, 3,3′-tolidene-4,4′diisocyanate, 3,3′-dimethyl-diphenylmethane-4,4′-diisocyanate, and combinations thereof. 6. The medical article of claim 1 , further comprising a plurality of chain extender residues. 7. The medical article of claim 6 , wherein the chain extender residues are selected from aliphatic diol residues, aromatic diol residues, aliphatic diamine residues and aromatic diamine residues. 8. The medical article of claim 6 , wherein the chain extender residues are selected from alpha,omega-C 1-C 10-alkane diol residues. 9. The medical article of claim 1 , comprising from 2 to 50 polyisobutylene segments. 10. The medical article of claim 1 , comprising from 2 to 50 biodegradable polymer segments. 11. The medical article of claim 1 , wherein the tubular member is a stent, a catheter, a lead, an orthopedic screw, a suture, a venous valve, a cardiac valve, a graft, an aneurysm coil, an adhesion prevention coating, a pelvic mesh, a hernia mesh, or a spinal disc replacement. 12. The medical article of claim 1 , wherein the polymeric region further comprises a therapeutic agent. 13. The medical article of claim 12 , wherein the therapeutic agent is an antirestenotic agent. 14. An implantable medical devices, comprising: a stent having a polymeric region, the polymeric region including a copolymer comprising a plurality of polyisobutylene segments having a number average molecular weight of 20,000 or less and a plurality of hard biodegradable polymer segments; and wherein the copolymer includes one or more linkages comprising a 1,2,3-triazole moiety.
from polyesters · CPC title
Rubbers · CPC title
derived from amino-carboxylic acids · CPC title
Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title
Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.